Publication Venue For
Peptide Based Imaging Agents for HER2 Imaging in Oncology
Targeting HER2 in Nuclear Medicine for Imaging and Therapy
Decreased Taurine and Creatine in the Thalamus May Relate to Behavioral Impairments in Ethanol-Fed Mice: A Pilot Study of Proton Magnetic Resonance Spectroscopy.
Cyclotron production of high-specific activity
Co and in vivo evaluation of the stability of
Co metal-chelate-peptide complexes
Preclinical positron emission tomographic imaging of acute hyperoxia therapy of chronic hypoxia during pregnancy
Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502.
Breast cancer imaging using the near-infrared fluorescent agent, CLR1502
Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor.
Development and characterization of
Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor
Imaging of CD47 expression in xenograft and allograft tumor models
Molecular imaging of gastric neoplasia with near-infrared fluorescent activatable probes
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging
Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography.
Novel infectivity-enhanced oncolytic adenovirus With a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer
Imaging of cardiotoxicity
Noninvasive monitoring of pneumococcal meningitis and evaluation of treatment efficacy in an experimental mouse model
Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)